-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$700.002942.16% Upside
Harpoon Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Harpoon Therapeutics, Inc.?
Harpoon Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Wedbush in the past 90 days.